Literature DB >> 31559846

Radiological diagnostic features of uremic leontiasis ossea: a case report.

Jingbo Wang1, Xue Zhao1, Huimin Shi1, Ling Zhu1, Xiaofeng Tao1.   

Abstract

Uremic leontiasis ossea (ULO), which occurs in the craniomaxillofacial region, is a sign of terminal stage osteitis fibrosa cystica or brown tumors and primarily caused by secondary hyperparathyroidism induced by renal failure. Pathophysiological changes include osteoclasts or osteoblasts proliferation, bone resorption, bone decalcification, and connective tissue proliferation. In this paper, we report a case of a 24-year-old female patient, who was diagnosed with ULO and presented with multiple facial swellings. Imaging features included zonal patterns with alternating rings of hypo- and hyperattenuated craniomaxillofacial bones, and diffused mixed sclerotic tissues with lytic changes in CT imaging. T1 weighted image and T2 weighted image in MRI were characterized by alternating rings of low and intermediate signal intensity patterns. To the best of our knowledge, this case is the first example of pathologically proved ULO with maxillofacial MRI.

Entities:  

Keywords:  Craniofacial Abnormality; Hyperparathyroidism; Osteitis Fibrosa Cystica; Renal Osteodystrophy

Mesh:

Year:  2019        PMID: 31559846      PMCID: PMC6957065          DOI: 10.1259/dmfr.20190253

Source DB:  PubMed          Journal:  Dentomaxillofac Radiol        ISSN: 0250-832X            Impact factor:   2.419


  5 in total

Review 1.  Leontiasis ossea caused by long-standing hyperparathyroidism secondary to chronic renal failure.

Authors:  Benjamin C James; Jessica L Hwang; Raymon H Grogan; Edwin L Kaplan; David Sarne; Peter Angelos
Journal:  Surgery       Date:  2014-09-22       Impact factor: 3.982

2.  Thyroid carcinoma found at parathyroidectomy: association with primary, secondary, and tertiary hyperparathyroidism.

Authors:  L A Burmeister; M Sandberg; S E Carty; C G Watson
Journal:  Cancer       Date:  1997-04-15       Impact factor: 6.860

Review 3.  Hyperparathyroidism.

Authors:  William D Fraser
Journal:  Lancet       Date:  2009-07-11       Impact factor: 79.321

4.  Uremic leontiasis ossea: "bighead" disease in humans? Radiologic, clinical, and pathologic features.

Authors:  V S Lee; M S Webb; S Martinez; C P McKay; G S Leight
Journal:  Radiology       Date:  1996-04       Impact factor: 11.105

5.  Symptomatic Primary Hyperparathyroidism as a Risk Factor for Differentiated Thyroid Cancer.

Authors:  Guadalupe Vargas-Ortega; Lourdes Balcázar-Hernández; Baldomero González-Virla; Claudia Ramírez-Rentería; Oriana Nieto-Guzmán; Ana Pamela Garrido-Mendoza; Marco Antonio Flores-Maya; Moisés Mercado; Mendoza-Zubieta Victoria
Journal:  J Thyroid Res       Date:  2018-11-18
  5 in total
  2 in total

1.  Uremic Leontiasis Ossea in a Pediatric Patient.

Authors:  Hisham K Algossy; Fahad Albadr; Abdullah Y Aloraini; Mohammed K Alsayyar; Abdullah H AlHindi
Journal:  Cureus       Date:  2022-03-23

2.  Uremic leontiasis ossea: distinctive imaging features allow differentiation from other clinical causes of leontiasis ossea.

Authors:  Ali Alamer
Journal:  Radiol Case Rep       Date:  2021-12-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.